We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

By MedImaging International staff writers
Posted on 12 Nov 2024
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms of coronary artery disease (CAD). The late-breaking results from the CONFIRM2 global multicenter study highlighted the key atherosclerotic features most strongly linked to major adverse cardiovascular events (MACE) and revealed that these features are more reliable than traditional clinical risk scores.

In this study, which involved 3,551 symptomatic patients from 18 sites across 13 countries, researchers at Leiden University Medical Center (Leiden, Netherlands) used cutting-edge AI technology to analyze coronary computed tomography angiography (CCTA) data. The analysis revealed that two specific factors were the strongest indicators of MACE: 1) % Diameter Stenosis and 2) Non-Calcified Plaque Volume. Additionally, the CONFIRM2 study demonstrated that coronary artery calcified plaque volume did not independently predict negative outcomes for patients. These findings suggest that AI-driven evaluations could play a significant role in shaping treatment decisions, improving patient outcomes, and reducing the incidence of cardiovascular events in individuals with CAD.

"The integration of AI in assessing coronary artery disease represents a transformative leap in our ability to predict and manage coronary heart disease-related events,” said Dr. James K. Min, Founder and CEO of Cleerly. “AI-QCT analysis of cardiac CT provides diameter stenosis percentages and an accurate view of non-calcified plaque volume based on millions of images. This research not only highlights the potential of AI to improve diagnostic accuracy but also the importance of early intervention in reducing the risk of serious cardiovascular events."

Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Half Apron
Demi
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
MRI System
nanoScan MRI 3T/7T

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.